Mortada Abbass
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mortada Abbass has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Olivier Uwishema
Department of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda
5 shared publications - Anushree Rai
Oli Health Magazine Organization, Research and Education, Kigali, Rwanda
4 shared publications - Irem Adanur
Oli Health Magazine Organization, Research and Education, Kigali, Rwanda
4 shared publications - Lama Uweis
Oli Health Magazine Organization, Research and Education, Kigali, Rwanda
4 shared publications - Rayyan El Saleh
Oli Health Magazine Organization, Research and Education, Kigali, Rwanda
4 shared publications - Nicholas Aderinto
Ladoke Akintola University of Technology, Ogbomosho, Nigeria
3 shared publications
Latest Publications
- Open Access
- 4 April 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (5) , 3023-3026
Unusual diagnosis in a Lebanese child with persistent hyper eosinophilia: a case report
Introduction and Importance: The differential diagnoses of hypereosinophilia (HE) are diverse and may include parasitic infections, allergic or atopic diseases, and malignancies. The list of differentials for hypereosinophilia is diverse and a comprehensive workup can often be expensive. However, it is essential to identify the underlying cause and treat it rather than treating eosinophilia itself. Case presentation: A 5-year-old male patient was referred to a pediatric hemato-oncologist for concerns of persistent hypereosinophilia, and the absolute eosinophil count (AEC) was greater than 1000 in three recent complete blood count with differentials. The child presented complaining of alternating waxing and waning right and left ankle and knee redness, hotness, pain, and decreased range of motion that occurred every 2 weeks, with associated lack of appetite, fatigue, constipation, and fever reaching 39°C. Clinical discussion: Malignant eosinophilic infiltration of the bone marrow versus a parasitic infection was on top of the differential diagnoses. Presentations of HE suggesting organ system involvement include fever, weight loss, wheezing, cough, dysphagia, vomiting, lack of appetite, diarrhea, arthralgia, and myalgia. Conclusion: Identifying the etiology of persistent hypereosinophilia can be challenging in the pediatric population and can have diverse presentations. The primary focus during initial HE assessment is on evaluating the severity of symptoms and potential organ damage. Major life-threatening diagnoses as malignancies and immune deficiencies must be ruled out first when the AEC is persistently elevated. Parasitic infections should be investigated according to the geographic endemicity.
- 4 April 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (5) , 3023-3026
Open AccessUnusual diagnosis in a Lebanese child with persistent hyper eosinophilia: a case report
Introduction and Importance: The differential diagnoses of hypereosinophilia (HE) are diverse and may include parasitic infections, allergic or atopic diseases, and malignancies. The list of differentials for hypereosinophilia is diverse and a comprehensive workup can often be expensive. However, it is essential to identify the underlying cause and treat it rather than treating eosinophilia itself. Case presentation: A 5-year-old male patient was referred to a pediatric hemato-oncologist for concerns of persistent hypereosinophilia, and the absolute eosinophil count (AEC) was greater than 1000 in three recent complete blood count with differentials. The child presented complaining of alternating waxing and waning right and left ankle and knee redness, hotness, pain, and decreased range of motion that occurred every 2 weeks, with associated lack of appetite, fatigue, constipation, and fever reaching 39°C. Clinical discussion: Malignant eosinophilic infiltration of the bone marrow versus a parasitic infection was on top of the differential diagnoses. Presentations of HE suggesting organ system involvement include fever, weight loss, wheezing, cough, dysphagia, vomiting, lack of appetite, diarrhea, arthralgia, and myalgia. Conclusion: Identifying the etiology of persistent hypereosinophilia can be challenging in the pediatric population and can have diverse presentations. The primary focus during initial HE assessment is on evaluating the severity of symptoms and potential organ damage. Major life-threatening diagnoses as malignancies and immune deficiencies must be ruled out first when the AEC is persistently elevated. Parasitic infections should be investigated according to the geographic endemicity.
- Open Access
- 5 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (10) , 6012-6020
Exploring the need for surgical face masks in operating room: a comprehensive literature review
Surgical face masks (SFM) are pivotal in preventing surgical site infections (SSI) in the operating room (OR). However, there are currently no specific recommendations for their most effective use. SFM effectiveness is influenced by factors such as material, fit, and duration of use, sparking ongoing debates about their benefits and risks in surgery. SFMs act as a protective barrier, but their ability to filter out harmful compounds is questioned. They can also impact communication and create a false sense of security. Nevertheless, SFMs aid in infection prevention and provide psychological comfort. Clear guidelines are needed to ensure their appropriate use in the OR. This paper offers a historical overview of surgical masks, emphasizing their role in infection prevention. It explores SFM effectiveness for both the surgical team and patients during surgery and considers their future in surgical settings. As we navigate the evolving landscape of SFMs, clear and concise guidelines are imperative to ensure their judicious and effective use in the OR. This paper serves as an essential resource for understanding the historical significance, contemporary efficacy, and prospective trajectory of SFMs in surgical practice.
- 5 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (10) , 6012-6020
Open AccessExploring the need for surgical face masks in operating room: a comprehensive literature review
Surgical face masks (SFM) are pivotal in preventing surgical site infections (SSI) in the operating room (OR). However, there are currently no specific recommendations for their most effective use. SFM effectiveness is influenced by factors such as material, fit, and duration of use, sparking ongoing debates about their benefits and risks in surgery. SFMs act as a protective barrier, but their ability to filter out harmful compounds is questioned. They can also impact communication and create a false sense of security. Nevertheless, SFMs aid in infection prevention and provide psychological comfort. Clear guidelines are needed to ensure their appropriate use in the OR. This paper offers a historical overview of surgical masks, emphasizing their role in infection prevention. It explores SFM effectiveness for both the surgical team and patients during surgery and considers their future in surgical settings. As we navigate the evolving landscape of SFMs, clear and concise guidelines are imperative to ensure their judicious and effective use in the OR. This paper serves as an essential resource for understanding the historical significance, contemporary efficacy, and prospective trajectory of SFMs in surgical practice.
- Open Access
- 12 October 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 507-519
Impact of antibiotic-coated sutures on surgical site infections: a second-order meta-analysis
Background: Surgical site infections (SSIs) pose a global challenge, impacting patients and healthcare expenditures. This second-order meta-analysis endeavors to assess the efficacy of antibiotic sutures in averting SSIs by amalgamating data from various meta-studies. Materials and methods: This research adhered to the PRISMA 2020 guidelines. The quality and comprehensiveness of the encompassed meta-analyses were assessed through the QUOROM checklist and AMSTAR techniques. The primary study overlap was evaluated via measures such as pairwise intersection heat maps, corrected covered area, and the citation matrix of evidence. The statistical power at the study-level was determined utilizing the meta-meta package. Data synthesis employed random and fixed effects models at a 95% CI. A meta-regression analysis was conducted to explore potential correlations between the CDC classification of SSIs, trial types, and the observed effect sizes in the studies. Results: This investigation revealed a significant reduction in SSI rates due to antimicrobial-coated sutures, evidenced by a relative risk (RR) of 0.68 (95% CI: 0.59–0.76), with a prediction interval of 0.38–1.19. The analysis encompassed 18 studies with 22 meta-analyses, demonstrating a median QUOROM score of 13.6 out of 18 and an AMSTAR score of 9.1 out of 11. The presence of moderate heterogeneity was noted (Q=106.611, I 2=54.038%), with nonrandomized controlled trials exhibiting an RR of 0.56 (95% CI: 0.39–0.80), and RCTs displaying an RR of 0.71 (95% CI: 0.63–0.81). Subgroup analysis unveiled variable RR reductions for specific surgical procedures. Conclusion: Antimicrobial-coated sutures offer a promising approach to mitigating SSIs risk. However, their efficacy is optimally realized when employed in conjunction with other robust practices.
- 12 October 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 507-519
Open AccessImpact of antibiotic-coated sutures on surgical site infections: a second-order meta-analysis
Background: Surgical site infections (SSIs) pose a global challenge, impacting patients and healthcare expenditures. This second-order meta-analysis endeavors to assess the efficacy of antibiotic sutures in averting SSIs by amalgamating data from various meta-studies. Materials and methods: This research adhered to the PRISMA 2020 guidelines. The quality and comprehensiveness of the encompassed meta-analyses were assessed through the QUOROM checklist and AMSTAR techniques. The primary study overlap was evaluated via measures such as pairwise intersection heat maps, corrected covered area, and the citation matrix of evidence. The statistical power at the study-level was determined utilizing the meta-meta package. Data synthesis employed random and fixed effects models at a 95% CI. A meta-regression analysis was conducted to explore potential correlations between the CDC classification of SSIs, trial types, and the observed effect sizes in the studies. Results: This investigation revealed a significant reduction in SSI rates due to antimicrobial-coated sutures, evidenced by a relative risk (RR) of 0.68 (95% CI: 0.59–0.76), with a prediction interval of 0.38–1.19. The analysis encompassed 18 studies with 22 meta-analyses, demonstrating a median QUOROM score of 13.6 out of 18 and an AMSTAR score of 9.1 out of 11. The presence of moderate heterogeneity was noted (Q=106.611, I 2=54.038%), with nonrandomized controlled trials exhibiting an RR of 0.56 (95% CI: 0.39–0.80), and RCTs displaying an RR of 0.71 (95% CI: 0.63–0.81). Subgroup analysis unveiled variable RR reductions for specific surgical procedures. Conclusion: Antimicrobial-coated sutures offer a promising approach to mitigating SSIs risk. However, their efficacy is optimally realized when employed in conjunction with other robust practices.
- Open Access
- 10 May 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah (7) , 2153-2156
Tomato flu outbreak in India: Why is it an impending public health emergency?- A correspondence
An abstract is unavailable. This article is available as a PDF only.
- 10 May 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. Publish Ah (7) , 2153-2156
Open AccessTomato flu outbreak in India: Why is it an impending public health emergency?- A correspondence
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 25 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 879-883
A minireview of cholera outbreak in Lebanon – a rising public health concern
Cholera is a highly contagious illness that can cause severe acute watery diarrhoea. The World Health Organisation (WHO) and the Lebanese Ministry of Health announced on the 10th of October 2022 the re-emergence of Cholera in Lebanon. Data was collected from the Ministry of Public Health in Lebanon, World Health Organization, news announcements, as well as from online databases such as PubMed, Science Direct, news, conferences and press releases on the current cholera outbreak. More than 669 cholera confirmed cases and 23 deaths have been reported in Lebanon up till December 29, 2022. The Ministry of Public Health is providing cooperation and support in containing the disease, and covering the hospital and treatment expenses for cholera patients. This paper aims to study the epidemiology of cholera, focusing on the most recent cholera outbreak in Lebanon, and to suggest some recommendations which can be followed to fight off this outbreak.
- 25 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 879-883
Open AccessA minireview of cholera outbreak in Lebanon – a rising public health concern
Cholera is a highly contagious illness that can cause severe acute watery diarrhoea. The World Health Organisation (WHO) and the Lebanese Ministry of Health announced on the 10th of October 2022 the re-emergence of Cholera in Lebanon. Data was collected from the Ministry of Public Health in Lebanon, World Health Organization, news announcements, as well as from online databases such as PubMed, Science Direct, news, conferences and press releases on the current cholera outbreak. More than 669 cholera confirmed cases and 23 deaths have been reported in Lebanon up till December 29, 2022. The Ministry of Public Health is providing cooperation and support in containing the disease, and covering the hospital and treatment expenses for cholera patients. This paper aims to study the epidemiology of cholera, focusing on the most recent cholera outbreak in Lebanon, and to suggest some recommendations which can be followed to fight off this outbreak.
- Open Access
- 14 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1348-1351
Is the New Langya virus in China a threat to global health? A short communication
The recently detected virus in eastern China in 2018 led to some health concerns, especially with the global trend of spreading viruses. As a new RNA-detected genus of the henipavirus family was found in Eastern China, the number of patients affected has reached 35 through zoonotic spread, with symptoms ranging from simple fever to fatal affection of vital organs such as the brain, liver, and kidneys. Researchers have found that shrew animals might be a potential reservoir for the Langya virus; however, data is still limited regarding human-to-human transmission. Current efforts by the Chinese Health Ministry and the Taiwan Centers for Disease Control and Prevention to deduct the spread of the virus and track its origin by trying to sequence the disease genome are evident. With all this in mind, the recommendation to face this new novel virus revolves around protecting the most vulnerable population at risk of being infected, such as farmers, and preventing the spread of the virus. Efforts must be directed toward screening animals for henipavirus and diving more deeply into the etiology of how this virus has spread to humans to help understand the spread of zoonotic viruses in the future.
- 14 March 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (4) , 1348-1351
Open AccessIs the New Langya virus in China a threat to global health? A short communication
The recently detected virus in eastern China in 2018 led to some health concerns, especially with the global trend of spreading viruses. As a new RNA-detected genus of the henipavirus family was found in Eastern China, the number of patients affected has reached 35 through zoonotic spread, with symptoms ranging from simple fever to fatal affection of vital organs such as the brain, liver, and kidneys. Researchers have found that shrew animals might be a potential reservoir for the Langya virus; however, data is still limited regarding human-to-human transmission. Current efforts by the Chinese Health Ministry and the Taiwan Centers for Disease Control and Prevention to deduct the spread of the virus and track its origin by trying to sequence the disease genome are evident. With all this in mind, the recommendation to face this new novel virus revolves around protecting the most vulnerable population at risk of being infected, such as farmers, and preventing the spread of the virus. Efforts must be directed toward screening animals for henipavirus and diving more deeply into the etiology of how this virus has spread to humans to help understand the spread of zoonotic viruses in the future.
- Open Access
- 3 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (5) , 1539-1542
Childhood tuberculosis outbreak in Africa: is it a matter of concern?
An abstract is unavailable. This article is available as a PDF only.
- 3 March 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (5) , 1539-1542
Open AccessChildhood tuberculosis outbreak in Africa: is it a matter of concern?
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 6 June 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 79, 103958
Ebola virus outbreak returns to the Democratic Republic of Congo: An urgent rising concern
On April 23, 2022, the Ministry of Health of the Democratic Republic of the Congo announced an EVD outbreak after discovering 2 confirmed cases and identifying 267 contacts. With collaboration from the WHO, the MoH are taking many interventions to prevent further expansion of this outbreak. Forty-six years ago, the Ebola virus was first discovered in 1976 near the Ebola River in the DRC. Since then, 13 outbreaks of EVD have occurred in the DRC and, in 2020, it witnessed the second largest EVD outbreak in the world, resulting in 3481 cases and 2299 mortalities. This article discusses the epidemiology of the current DRC outbreak by examining the etiology of EVD, the number of affected cases, and the subsequent case index. Considering these data, this paper discusses measures taken by the MoH, WHO, CDC, and UNICEF to mitigate the Ebola outbreak, such as supporting local teams to provide essential care, training medical staff, and raising awareness for vaccination. Finally, by comparing the gravity of the situation to current measures, this article provides recommendations for individuals and governments to protect themselves and mitigate future outbreaks.
- 6 June 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 79, 103958
Open AccessEbola virus outbreak returns to the Democratic Republic of Congo: An urgent rising concern
On April 23, 2022, the Ministry of Health of the Democratic Republic of the Congo announced an EVD outbreak after discovering 2 confirmed cases and identifying 267 contacts. With collaboration from the WHO, the MoH are taking many interventions to prevent further expansion of this outbreak. Forty-six years ago, the Ebola virus was first discovered in 1976 near the Ebola River in the DRC. Since then, 13 outbreaks of EVD have occurred in the DRC and, in 2020, it witnessed the second largest EVD outbreak in the world, resulting in 3481 cases and 2299 mortalities. This article discusses the epidemiology of the current DRC outbreak by examining the etiology of EVD, the number of affected cases, and the subsequent case index. Considering these data, this paper discusses measures taken by the MoH, WHO, CDC, and UNICEF to mitigate the Ebola outbreak, such as supporting local teams to provide essential care, training medical staff, and raising awareness for vaccination. Finally, by comparing the gravity of the situation to current measures, this article provides recommendations for individuals and governments to protect themselves and mitigate future outbreaks.